Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Feb;175(2):169-70.
doi: 10.1001/jamainternmed.2014.4299.

The ongoing debate of who to treat for chronic hepatitis C virus

Marc G Ghany  1
Affiliations
Editorial

The ongoing debate of who to treat for chronic hepatitis C virus

Marc G Ghany. JAMA Intern Med. 2015 Feb.

Abstract

Chronic hepatitis C virus (HCV) infection is a major cause of cirrhosis and hepatocellular carcinoma worldwide and the leading indication for liver transplantation in the adult United States population. Although the incidence of chronic HCV infection is declining, the number of deaths is projected to rise over the next decade. Hence, the major reason for treating chronic HCV infection is to mitigate the morbidity and mortality associated with the infection but also to alleviate patient symptoms and to prevent person-to-person transmission. Successful eradication or virological cure is possible and a reduction in liver-related outcomes has been demonstrated in patients with advanced liver disease who achieve this desirable endpoint.–

PubMed Disclaimer

Comment on

  • Liver fibrosis progression in hepatitis C virus infection after seroconversion.
    Butt AA, Yan P, Lo Re V 3rd, Rimland D, Goetz MB, Leaf D, Freiberg MS, Klein MB, Justice AC, Sherman KE; ERCHIVES (Electronically Retrieved Cohort of HCV Infected Veterans) Study Team. Butt AA, et al. JAMA Intern Med. 2015 Feb;175(2):178-85. doi: 10.1001/jamainternmed.2014.6502. JAMA Intern Med. 2015. PMID: 25485735 Free PMC article.

References

    1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. December 15 2012;380(9859):2095–2128. - PMC - PubMed
    1. 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999–2008. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2010.
    1. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. February 2010;138(2):513–521, 521 e511–516. - PubMed
    1. van der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA : the journal of the American Medical Association. December 26 2012;308(24):2584–2593. - PubMed
    1. Veldt BJ, Heathcote EJ, Wedemeyer H, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Annals of internal medicine. November 20 2007;147(10):677–684. - PubMed